Navigation Links
Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease
Date:1/8/2014

WHAT:

The final agenda for the Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://www.crf.org/celltherapy/the-conference/agenda. The conference, which will be held January 22-24, 2014, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will also be highlighted as measures of the progress ahead.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 13th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has provided both a strong foundation for the conduct of large scale, pivotal studies, as well as insights into mechanisms of cardiovascular repair that will enhance the design of further investigation.

Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies. Sessions will focus on:

  • Molecular and Cellular Pathways: Regulating Biologic Function
  • Mechanistic Insights and Hypothesis
  • Moving Toward Tissue as Therapy: Micro- and Macro-Structure Strategies
  • STEMI and Acute Injury Studies
  • Chronic Injury and Vascular Insufficiency
  • Chronic Left Ventricular Dysfunction and Heart Failure
  • Patients-In-Need: Defining and Refining our Approach to Target Populations
  • Data in Hand: Looking for Answers in Meta-Analytic Studies
  • Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine

WHO:

Course Director

Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors

Jozef Bartunek, MD, PhD

Henricus J. Duckers, MD, PhD

Amit Patel, MD, MS

Marc S. Penn, MD, PhD

Thomas Povsic, MD

Gordana Vunjak-Novakovic, PhD

Joseph Wu, MD, PhD

Wojtek Wojakowski, MD, PhD

WHEN:

January 22-24, 2014

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://www.crf.org/celltherapy.

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related biology news :

1. Planet under Pressure conference, London: Final statement
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. Finalists of air pollution sensor challenge announced
5. Dark matter made visible before the final cut
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. WPI Biomedical Technology in final 4 of international business plan contest
8. Final chapter to 60-year-old blood group mystery
9. Fueling fitness on the final frontier
10. Finally mapped: The brain region that distinguishes bits from bounty
11. The Sackler Institute unveils a global research agenda for nutrition science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):
(Date:5/31/2016)... ... ... Scientists at two major cancer research centers say older patients who have ... are younger. Surviving Mesothelioma has just published an article on the new research. ... Universities analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database to determine ...
(Date:5/27/2016)... ... 27, 2016 , ... Weeks after hosting a carpal tunnel syndrome workshop with ... surgeon and founder of the Fitzmaurice Hand Institute, has announced the addition of MRI ... state-of-the-art technology and only 1 of about 3 currently available in the United States. ...
(Date:5/26/2016)... May 26, 2016  Agriculture nutrients are in the ... Iowa is running their nitrate removal system ... Erie and coastal regions nationwide are painting ... this widespread issue. NECi Superior Enzymes, a ... Peninsula, developed a new, easy to use device that ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... and manufacturing company, today announced several positive developments that position the Company for ... a result of the transaction, Craig F. Kinghorn has been appointed Chairman of ...
Breaking Biology Technology: